Navigation Links
InVitria Launches Zap-CHO to Enhance CHO Cell Culture Performance
Date:10/1/2009

With Zap-CHO, customers get the animal free benefit of hydrolysates, the performance of FBS and the consistency of a defined media.

Fort Collins, CO (PRWEB) October 4, 2009 -- InVitria has launched a new and robust cell culture supplement for CHO (Chinese hamster ovaries) cell line enhancement called Zap-CHO. Zap-CHO is designed to deliver superior growth, maximum antibody productivity and faster cell line development and seed train expansion.

"Zap-CHO is a significant breakthrough in mammalian cell culture systems," said Dr. Steve Pettit, InVitria's Director of Cell Culture Development. "With the development of Zap-CHO, InVitria has created a performance enhancing CHO media supplement that is the first animal free supplement capable of replacing fetal bovine serum (FBS) without sacrificing performance and maintaining a well defined media. Since Zap-CHO is a defined and animal component-free product, it is well suited for commercial, chemically-defined and serum- and animal-free cell culture media formulations," said Dr. Pettit.

Zap-CHO is a next generation media supplement that delivers consistent cell culture performance. Previously, only FBS could deliver equivalent performance, but safety concerns of a fetal bovine component in cell culture media forced many customers away from this component. In the last decade, customers have eliminated FBS in cell culture media only to lose cell culture performance. To regain the lost performance, many began adding hydrolysates to the media. However, hydrolysates introduced significant variability, leading to failed experiments and production failures. Zap-CHO addresses these concerns and provides significant benefits in CHO cell culture, including:

 
  • Faster cell line development and seed train expansion
  • Animal component-free
  • Consistency of a defined media component
  • Biomanufacturing optimization and improved production economics
  • Better and more predictable performance in cell culture research and development

"Our product development team created Zap-CHO to exceed the needs of our customers working in CHO cell culture," said Scott Deeter, InVitria's President and CEO. "Our customers have realized exceptional performance results using Zap-CHO. InVitria's products, like Zap-CHO, are creating a new era for the cell culture manufacturing industry."

About InVitria
InVitria develops, manufactures and markets a portfolio of high performance and well defined cell culture media components and reagents used in bioprocessing, biopharmaceutical formulation, stem cell & regenerative medicine, life science research, medical devices and diagnostics.

For more information about InVitria's products or to order, please contact InVitria at info@invitria.com or call 1-800-916-8311. InVitria's products can also be purchased online Click Here.

###

Read the full story at http://www.prweb.com/releases/InVitria-ZapCHO/CHO-cell-culture-media/prweb2975014.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. InVitria's Better Ingredients for Better Media to be Showcased at BPI '09
2. InVitria Presents Zap-CHO Performance Results at PEACe Conference
3. InVitria Successfully Completes Beta Testing and Announces Commercial Launch of Optiferrin for Mammalian Cell Culture
4. InVitria Cell Culture Product Line to Headline PEACe
5. InVitria Sponsors ESACT 2009 in Dublin, Ireland
6. InVitria to Present at BIO 2009 International Convention in Atlanta
7. InVitria Reveals Technology to Optimize Hybridoma Production Performance
8. InVitria Headlines Sponsorship of WilBio's Waterside Conference
9. InVitria Announces Launch of Recombinant Albumin for Diagnostics
10. InVitria's Cell Culture Media Components Showcased at WilBio's 2008 Cell Engineering Meeting
11. InVitria's Cellastim Delivers Superior Results in CHO Cell Culture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS ... Designed to provide the most effective tattoo removal today, Dr. Bentkover is the only ... Developed by Cynosure, the PicoSure has been approved by the Food and Drug Administration ...
(Date:2/5/2016)... ... 05, 2016 , ... Colorize is a web theme package created ... next using Colorize's dynamic moving camera. Colorize is perfect for personal and web related ... environment with 1 to 5 focus points per scene, stage floor scene presets that ...
(Date:2/5/2016)... ... ... Health and wellness is a topic that should concern all Americans; however, ... an illness. Migraines are a severe form of a headache and often are accompanied ... the pain on their worst enemy, the feeling can last for many hours and ...
(Date:2/5/2016)... Ramsey, NJ (PRWEB) , ... February 05, 2016 ... ... Optimizing Primary Care for Patients with Rare Diseases, a continuing medical education (CME) ... conference is the first of its kind—and a first for ACCORD, whose mission ...
(Date:2/5/2016)... ... February 05, 2016 , ... KICVentures ( http://www.kicventures.com ) announced ... in New York City on Thursday, January 21, 2016. Kingsley R. Chin, ... alumnus of the varsity Columbia soccer program) spoke at the event, offering professional ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)...  The Senior Care Pharmacy Coalition (SCPC) today ... Jason Chaffetz (R-UT) and Ranking Member ... , "Developments in the Prescription Drug Market," to ... about abusive pharmacy benefit manager (PBM) pricing practices. ... Member Elijah Cummings (D-MD) are diligent, serious lawmakers ...
(Date:2/4/2016)... , Feb. 4, 2016  Montoya Love is ... in the field of Pharmaceuticals. Montoya is the Regulatory ... Manufacturing and ... Becton Dickinson provides healthcare institutions, clinical laboratories ... throughout fifty countries across the globe. ...
(Date:2/4/2016)... Mettler-Toledo International Inc. (NYSE: MTD ) today announced ... highlights: , Sales in local currency increased ... Reported sales decreased 3% as currency reduced sales growth ... per diluted share as reported (EPS) were $4.44, compared ... was $4.65, an increase of 10% over the prior-year ...
Breaking Medicine Technology: